Cardiovascular Disease

Businesswire logo
Feb 25, 2025
Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, is hosting an R&D Day today in New York…
Read more
Businesswire logo
Feb 25, 2025
Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, is hosting an R&D Day today in New York…
Read more
Subscribe to